The Role of PML in Tumor Suppression

Slides:



Advertisements
Similar presentations
p53 Revealed character as a tumor suppressor gene in 1989.
Advertisements

A Role for Dystroglycan in Basement Membrane Assembly Michael D Henry, Kevin P Campbell Cell Volume 95, Issue 6, Pages (December 1998) DOI: /S (00)
MiR-137 Modulates a Tumor Suppressor Network-Inducing Senescence in Pancreatic Cancer Cells Mathieu Neault, Frédérick A. Mallette, Stéphane Richard Cell.
Gene Expression (Epigenetics) Chapter 19. What you need to know The functions of the three parts of an operon. The role of repressor genes in operons.
Molecular Genetics: Part 2B Regulation of metabolic pathways:
Gene Expression.
Regulation of Gene Expression
EMT: Matter of Life or Death?
VHL Inactivation: A New Road to Senescence
B lymphocytes produce antibodies.
Mutant p53 gain of function: The NF-Y connection
K. Lenhard Rudolph, Daniel Hartmann, Oliver G. Opitz  Gastroenterology 
Approaching TERRA Firma: Genomic Functions of Telomeric Noncoding RNA
Volume 9, Issue 2, Pages (February 2002)
Dan Gordon  Gastroenterology  Volume 114, Issue 4, (April 1998)
Regulation of Gene Expression
p53 and Apoptosis: It's Not Just in the Nucleus Anymore
Is Hepatitis C Virus Carcinogenic?
Beyond Making Ends Meet: DNA-PK, Metabolism, and Aging
Cell signaling and cancer
Beyond Making Ends Meet: DNA-PK, Metabolism, and Aging
Transcriptional Noise and Somatic Mutations in the Aging Pancreas
Deregulating EMT and Senescence: Double Impact by a Single Twist
Epithelial-Mesenchymal Transitions
Methed-Up FOXOs Can't In-Akt-ivate
Wnt/β-Catenin Signaling: Turning the Switch
Cellular Senescence in Cancer and Aging
DNA-Damage Response in Tissue-Specific and Cancer Stem Cells
Tumor Necrosis Factor Cell
Review Warm-Up What is the Central Dogma?
Review Warm-Up What is the Central Dogma?
p53 and Metabolism: The GAMT Connection
Apoptosis-targeted therapies for cancer
P Bodies and the Control of mRNA Translation and Degradation
Volume 36, Issue 1, Pages 2-14 (October 2009)
The p27Kip1 tumor suppressor gene: Still a suspect or proven guilty?
Volume 3, Issue 4, Pages (April 2003)
PAF Makes It EZ(H2) for β-Catenin Transactivation
Eukaryotic Transcription Activation: Right on Target
Deregulating EMT and Senescence: Double Impact by a Single Twist
miR-34a and the Cardiomyopathy of Senescence: SALT PNUTS, SALT PNUTS!
Volume 70, Issue 7, Pages (October 2006)
John D. Hayes, Albena T. Dinkova-Kostova  Molecular Cell 
Schematic model of effector pathways that mediate tumor suppression by p53. Schematic model of effector pathways that mediate tumor suppression by p53.
Tumor Suppression by p53: Fall of the Triumvirate?
Into Thin Air: How We Sense and Respond to Hypoxia
A New FOXO Pathway Required for Leukemogenesis
Proteins Kinases: Chromatin-Associated Enzymes?
Hard Times for Oncogenic BRAF-Expressing Melanoma Cells
Blinded by the Light: The Growing Complexity of p53
A Versatile Transcriptional Effector of Wingless Signaling
Apoptosis-targeted therapies for cancer
John D. Gordan, Craig B. Thompson, M. Celeste Simon  Cancer Cell 
Review Warm-Up What is the Central Dogma?
John D. Hayes, Albena T. Dinkova-Kostova  Molecular Cell 
P53 and Prognosis Cell Volume 120, Issue 1, Pages 7-10 (January 2005)
Apoptosis Cell Volume 108, Issue 2, Pages (January 2002)
Long Noncoding RNAs and Hepatocellular Carcinoma
Slugging It out: Fine Tuning the p53-PUMA Death Connection
RelA Life and Death Decisions
Volume 119, Issue 4, Pages (October 2000)
Methylglyoxal Comes of AGE
Volume 4, Issue 4, Pages (October 2003)
Is Cyclin D1-CDK4 kinase a bona fide cancer target?
Tenets of PTEN Tumor Suppression
Histone deacetylase inhibitors in cancer therapy
Anthony N. Imbalzano, Stephen N. Jones  Cancer Cell 
PTEN and p53: Who will get the upper hand?
Volume 3, Issue 4, Pages (April 2003)
No Driver behind the Wheel? Targeting Transcription in Cancer
Presentation transcript:

The Role of PML in Tumor Suppression Paolo Salomoni, Pier Paolo Pandolfi  Cell  Volume 108, Issue 2, Pages 165-170 (January 2002) DOI: 10.1016/S0092-8674(02)00626-8

Figure 1 The PML-NB Modulates p53-Dependent Pathways for Tumor Suppression Oncogenic transformation and DNA damage elicit cellular senescence or induction of apoptosis. These processes are regulated by the tumor suppressor p53. PML controls the targeting of p53 into the PML-NB, its acetylation and transcriptional activation. As a consequence, p53 target genes relevant for either apoptosis or senescence are transcribed. Cell 2002 108, 165-170DOI: (10.1016/S0092-8674(02)00626-8)

Figure 2 The PML-NB Regulates the Assembly and Function of Transcription Factor Complexes Required for Tumor Suppression PML controls the NB-dependent acetylation of p53 by p300/CBP and its transcriptional activation for apoptosis or cellular senescence (left box). The transcription corepressor DAXX is targeted into the PML-NB, from where it modulates DISC-dependent apoptosis (middle box). PML-NB accumulation of an HDAC/N-CoR/Ski-repressing complex is required for MAD and Rb transcription (right box). Cell 2002 108, 165-170DOI: (10.1016/S0092-8674(02)00626-8)